Pharmaceutical compositions and methods of using C-21...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S365000, C536S051000, C548S204000

Reexamination Certificate

active

07053069

ABSTRACT:
Pharmaceutical compositions containing C-21 modified epothilone derivatives, methods for their preparation and dosing regimen for administration of these epothilone compounds are provided. The compositions are stable and readily prepared for administration by dissolution in aqueous vehicles suitable for intravenous administration. A process for formulating C-21 modified epothilone derivatives for oral and parenteral administration is disclosed.

REFERENCES:
patent: 6380227 (2000-09-01), Mutz
patent: 6194181 (2001-02-01), Hofmann et al.
patent: 6204388 (2001-03-01), Danishefsky et al.
patent: 6211412 (2001-04-01), Georg et al.
patent: 6242469 (2001-06-01), Danishefsky et al.
patent: 6262094 (2001-07-01), Hoefle et al.
patent: 6316630 (2001-11-01), Danishefsky et al.
patent: 6365749 (2002-04-01), Kim et al.
patent: 6369234 (2002-04-01), Danishefsky et al.
patent: 6380394 (2002-04-01), Nicolaou et al.
patent: 6518421 (2003-02-01), Li et al.
patent: 6576651 (2003-06-01), Bandyopadhyay et al.
patent: 6605599 (2003-08-01), Vite et al.
patent: 6635666 (2003-10-01), O'Reilly et al.
patent: 6670384 (2003-12-01), Bandyopadhyay et al.
patent: 6686380 (2004-02-01), Lee
patent: 2002/0143038 (2002-10-01), Bandyopadhyay et al.
patent: 2002/0165257 (2002-11-01), Lee
patent: 2003/0073677 (2003-04-01), Lee
patent: 2003/0187039 (2003-10-01), Favreau et al.
patent: 2003/0220378 (2003-11-01), Lee
patent: 2004/0024032 (2004-02-01), Vol et al.
patent: 4138042.8 (1993-05-01), None
patent: 19542986.9 (1997-05-01), None
patent: 19639456.2 (1997-05-01), None
patent: 19636343.8 (1998-03-01), None
patent: 19645361.5 (1998-04-01), None
patent: 19645362.3 (1998-04-01), None
patent: 19647580.5 (1998-05-01), None
patent: 19701758 (1998-07-01), None
patent: 19707505.3 (1998-09-01), None
patent: 19713970 (1998-10-01), None
patent: 19720312 (1998-11-01), None
patent: 19821954 (1998-11-01), None
patent: 19726627 (1998-12-01), None
patent: 879 605 (1998-11-01), None
patent: 93/10121 (1993-05-01), None
patent: 97/19086 (1997-05-01), None
patent: 98/08849 (1998-03-01), None
patent: 98/22461 (1998-05-01), None
patent: 98/24427 (1998-06-01), None
patent: 98/25929 (1998-06-01), None
patent: 98/38192 (1998-09-01), None
patent: 98/47891 (1998-10-01), None
patent: 99/01124 (1999-01-01), None
patent: 99/02514 (1999-01-01), None
patent: 99/03848 (1999-01-01), None
patent: 99/07692 (1999-02-01), None
patent: 99/27890 (1999-06-01), None
patent: 99/39694 (1999-08-01), None
patent: 99/42602 (1999-08-01), None
patent: 99/43320 (1999-09-01), None
patent: 99/43653 (1999-09-01), None
patent: 99/54319 (1999-10-01), None
patent: 99/67252 (1999-12-01), None
patent: 00/00485 (2000-01-01), None
patent: 00/31247 (2000-06-01), None
patent: 00/37473 (2000-06-01), None
patent: WO 00/39276 (2000-07-01), None
patent: 00/49021 (2000-08-01), None
patent: 00/66589 (2000-11-01), None
Balog, A., et al., “Total Synthesis of (−)-Epothilone A”,Angew. Chem. Int. Ed. Engl., vol. 35, No. 23/24, 2801-2803 (1996).
Bertini, F., et al., “Alkenes from Epoxides by Reductive Elimination with Magnesium Bromide-Magnesium Amalgam”,Chem. Commun., 144 (1970).
Bollag, D.M., et al., “Epothilones, A New Class of Microtubule-stabilizing Agents with a Taxol-like Mechanism of Action”,Cancer Res.55, No. 11, 2325-2333 (1995).
Fujisawa, T., et al., “Deoxygenation of Epoxides to Olefins with FeCl3—-BuLi System”,Chem. Lett., 883-886 (1974).
Fujiwara, Y., et al., “Reductive Coupling of Carbonyl Compounds to Olefins by Tungsten Hexachloride-Lithium Aluminum Hydride and Some Tungsten and Molybdenum Carbonyls”,J. Org. Chem., vol. 43, No. 12, 2477-2479 (1978).
Gladysz, J. A., et al., “Deoxygenation of Epoxides by Metal Atom Cocondensation”,J. Org. Chem., vol. 41, No. 22, 3647-3648 (1976).
Hofle, G., et al., “Epothilone A and B—Novel 16-Membered Macrolides with Cytotoxic Activity: Isolation, Crystal Structure, and Conformation in Solution”,Angew. Chem. Int. Ed. Engl., vol. 35, No. 13/14, 1567-1569 (1996).
Hofle, G., et al., “N-Oxidation of Epothilone A-C and O-Acyl Rearrangement to C-19 and C-21—Substituted Epothilones”,Angew. Chem. Int. Ed., vol. 38, No. 13/14, 1971-1974 (1999).
Inokuchi, T., et al., “Opening of Epoxides to Olefins or Halohydrins with Vanadium(II)-Tetrahydrofuran or Vanadium(III)-Tetrahydrofuran Complexes”,Synlett, No. 6, 510-512 (1992).
Kowalski. R. J., et al., “Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®)”J. Biol. Chem., vol. 272, No. 4, 2534-2541 (1997).
Kupchan, S. M., et al., “Reductive Elimination of Epoxides to Olefins with Zinc-Copper Couple”,J. Org. Chem., vol. 36, No. 9, 1187-1190 (1971).
Martin, M. G., et al., “Epoxides as Alkene Protecting Groups. A Mild and Efficient Deoxygenation”,Tetrahedron Letters, vol. 25, No. 3, 251-254 (1984).
McMurry, J. E., et al., “Reduction of Epoxides to Olefins with Low Valent Titanium”,J. Org. Chem., vol. 40, No. 17, 2555-2556 (1975).
McMurry, J. E., et al., “Some Deoxygenation Reactions with Low-Valent Titanium (TiCl3/LiAlH4)”,J. Org. Chem., vol. 43, No. 17, 3249-3254 (1978).
Meng, D., et al., “Remote Effects in Macrolide Formation Through Ring-Forming Olefin Metathesis: An Application to the Synthesis of Fully Active Epothilone Congeners”,J. Am. Chem. Soc., vol. 119, No. 11, 2733-2734 (1997).
Nicolaou, K. C., et al., “An Approach to Epothilones Based on Olefin Metathesis”,Angew. Chem. Int. Ed. Engl., vol. 35, No. 20, 2399-2401 (1996).
Nicolaou, K. C., et al., “Total Synthesis of Epothilone A: The Macrolactonization Approach”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 5, 525-527 (1997).
Nicolaou, K. C., et al., “Designed Epothilones: Combinatorial Synthesis, Tubulin Assembly Properties, and Cytotoxic Action against Taxol-Resistant Tumor Cells”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 19, 2097-2103 (1997).
Nicolaou, K.C., et al., “The Olefin Metathesis Approach to Epothilone A and Its Analogues”,J. Am. Chem. Soc., vol. 119, No. 34, 7960-7973 (1997).
Nicolaou, K. C., et al., “Total Syntheses of Epothilones A and B via a Macrolactonization-Based Strategy”,J. Am. Chem. Soc., vol. 119, No. 34, 7974-7991 (1997).
Nicolaou, K. C., et al., “Synthesis of Epothilones A and B in Solid and Solution Phase”,Nature, vol. 387, 268-272 (1997).
Nicolaou, K. C., et al., “Synthesis of Epothilones A and B in Solid and Solution Phase” (Correction toNature387, 268-272 (1997)),Nature, 390, 100 (1997).
Raucher, S., et al., “Total Synthesis of (+)-Dihydrocostunolide via Tandem Cope-Claisen Rearrangement”,J. Org. Chem., vol. 51, No. 26, 5503-5505 (1986).
Sato, M, et al., “Reduction of Organic Compounds with Low-Valent Niobium (NbCl5/NaAlH4)”,Chem. Letters, 157-160 (1982).
Schinzer, D., et al., “Total Synthesis of (−)-Epothilone A”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 5, 523-524 (1997).
Schobert, R., et al., “Reduction and Isomerization of Oxiranes and α-Diazoketones by Various Early Transition Metallocenes”,Synlett, vol. 8, 465-466 (1990).
Sharpless, K. B., et al., “Lower Valent Tungsten Halides. A New Class of Reagents for Deoxygenation of Organic Molecules”,J. Amer. Chem. Soc., vol. 94, No. 18, 6538-6540 (1972).
Su, D.-S., et al., “Total Synthesis of (−)-Epothilone B: An Extension of the Suzuki Coupling Method and Insights into Structure-Activity Relationships of the Epothilones”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 7, 757-759 (1997).
Su, D.-S., et al., “Structure-Activity Relationships of the Epothilones and the First In Vivo Comparison with Paclitaxel”,Angew. Chem. Int. Ed. Engl., vol. 36, No. 19, 2093-2096 (1997).
Victory, S. F., et al., “Relative Stereochemistry and Solution Conformat

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions and methods of using C-21... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions and methods of using C-21..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions and methods of using C-21... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3531466

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.